These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 29703589

  • 1. Increased GPNMB, phospho-ERK1/2, and MMP-9 in cystic fibrosis in association with reduced arylsulfatase B.
    Bhattacharyya S, Feferman L, Sharma G, Tobacman JK.
    Mol Genet Metab; 2018 Jun; 124(2):168-175. PubMed ID: 29703589
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF.
    Bhattacharyya S, Feferman L, Tobacman JK.
    PLoS One; 2016 Jun; 11(4):e0153463. PubMed ID: 27078017
    [Abstract] [Full Text] [Related]

  • 3. Effect of CFTR modifiers on arylsulfatase B activity in cystic fibrosis and normal human bronchial epithelial cells.
    Bhattacharyya S, Feferman L, Tobacman JK.
    Pulm Pharmacol Ther; 2016 Feb; 36():22-30. PubMed ID: 26656789
    [Abstract] [Full Text] [Related]

  • 4. Reduced Arylsulfatase B activity in leukocytes from cystic fibrosis patients.
    Sharma G, Burke J, Bhattacharyya S, Sharma N, Katyal S, Park RL, Tobacman J.
    Pediatr Pulmonol; 2013 Mar; 48(3):236-44. PubMed ID: 22550062
    [Abstract] [Full Text] [Related]

  • 5. Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR.
    Bhattacharyya S, Look D, Tobacman JK.
    Clin Chim Acta; 2007 May 01; 380(1-2):122-7. PubMed ID: 17324393
    [Abstract] [Full Text] [Related]

  • 6. Oxidative stress induces extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase in cystic fibrosis lung epithelial cells: Potential mechanism for excessive IL-8 expression.
    Boncoeur E, Criq VS, Bonvin E, Roque T, Henrion-Caude A, Gruenert DC, Clement A, Jacquot J, Tabary O.
    Int J Biochem Cell Biol; 2008 May 01; 40(3):432-46. PubMed ID: 17936667
    [Abstract] [Full Text] [Related]

  • 7. Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells.
    Bhattacharyya S, Feferman L, Han X, Ouyang Y, Zhang F, Linhardt RJ, Tobacman JK.
    J Biol Chem; 2018 Jul 13; 293(28):11076-11087. PubMed ID: 29794138
    [Abstract] [Full Text] [Related]

  • 8. Decline in arylsulfatase B leads to increased invasiveness of melanoma cells.
    Bhattacharyya S, Feferman L, Terai K, Dudek AZ, Tobacman JK.
    Oncotarget; 2017 Jan 17; 8(3):4169-4180. PubMed ID: 27926479
    [Abstract] [Full Text] [Related]

  • 9. Does deficiency of arylsulfatase B have a role in cystic fibrosis?
    Tobacman JK.
    Chest; 2003 Jun 17; 123(6):2130-9. PubMed ID: 12796199
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of estrogen exposure on arylsulfatase B, galactose-6-sulfatase, and steroid sulfatase in rat prostate development.
    Feferman L, Bhattacharyya S, Birch L, Prins GS, Tobacman JK.
    J Steroid Biochem Mol Biol; 2014 Sep 17; 143():105-14. PubMed ID: 24508597
    [Abstract] [Full Text] [Related]

  • 11. Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A.
    Bhattacharyya S, Feferman L, Tobacman JK.
    Biochim Biophys Acta; 2015 Mar 17; 1849(3):342-52. PubMed ID: 25511584
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Arylsulfatase B (N-acetylgalactosamine-4-sulfatase): potential role as a biomarker in prostate cancer.
    Feferman L, Bhattacharyya S, Deaton R, Gann P, Guzman G, Kajdacsy-Balla A, Tobacman JK.
    Prostate Cancer Prostatic Dis; 2013 Sep 17; 16(3):277-84. PubMed ID: 23835622
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling.
    Bhattacharyya S, O-Sullivan I, Tu J, Chen Z, Tobacman JK.
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan 17; 1870(1):166913. PubMed ID: 37813168
    [Abstract] [Full Text] [Related]

  • 16. Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3.
    Bhattacharyya S, Feferman L, Tobacman JK.
    J Biol Chem; 2014 Jun 20; 289(25):17564-75. PubMed ID: 24778176
    [Abstract] [Full Text] [Related]

  • 17. Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin.
    Kotlo K, Bhattacharyya S, Yang B, Feferman L, Tejaskumar S, Linhardt R, Danziger R, Tobacman JK.
    Glycoconj J; 2013 Oct 20; 30(7):667-76. PubMed ID: 23385884
    [Abstract] [Full Text] [Related]

  • 18. Cell-bound IL-8 increases in bronchial epithelial cells after arylsulfatase B silencing due to sequestration with chondroitin-4-sulfate.
    Bhattacharyya S, Solakyildirim K, Zhang Z, Chen ML, Linhardt RJ, Tobacman JK.
    Am J Respir Cell Mol Biol; 2010 Jan 20; 42(1):51-61. PubMed ID: 19346317
    [Abstract] [Full Text] [Related]

  • 19. Toll-like receptors 4 and 2 expression in the bronchial mucosa of patients with cystic fibrosis.
    Hauber HP, Tulic MK, Tsicopoulos A, Wallaert B, Olivenstein R, Daigneault P, Hamid Q.
    Can Respir J; 2005 Jan 20; 12(1):13-8. PubMed ID: 15776129
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.